• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有膀胱控制问题的女性的认知与行为

Perceptions and behaviours of women with bladder control problems.

作者信息

Diokno Ananias C, Sand Peter K, Macdiarmid Scott, Shah Rajul, Armstrong Robert B

机构信息

Department of Urology, William Beaumont Hospital, Royal Oak, MI 48073-6710, USA.

出版信息

Fam Pract. 2006 Oct;23(5):568-77. doi: 10.1093/fampra/cml018. Epub 2006 May 26.

DOI:10.1093/fampra/cml018
PMID:16731545
Abstract

OBJECTIVES

To evaluate women's perceptions about bladder control problems.

METHODS

757 Women with one or more bladder control symptoms (frequency, urgency, stress or urge urinary incontinence and nocturia) participated in an Internet-based survey. A separate study involved 12 focus groups including a total of 180 women with bladder control problems.

RESULTS

Respondents in the survey reported multiple symptoms, e.g. stress urinary incontinence (72%), frequency (56%), nocturia (45%), urge urinary incontinence (43%) and urgency (33%). Women in both the survey and the focus groups revealed extensive use of coping mechanisms to manage their symptoms. The focus groups revealed that many women were not aware that overactive bladder (OAB) is a pathophysiological condition. Approximately 30% of respondents in the survey felt uncomfortable talking to their doctor about their condition. Among women who did speak with their doctor, stress-related symptoms were described more readily than urge-related symptoms. In the survey, only about half (56%) of the women felt their OAB medication was effective, and half (50%) stopped taking their medication at some point. Information from the focus groups suggested that some women may have unrealistic expectations of onset of efficacy or extent of benefit and may be unprepared for managing side effects.

CONCLUSIONS

Feelings of embarrassment and limited understanding of the pathophysiology of OAB can contribute to miscommunication between a woman and her doctor. Patient education regarding reasonable expectations coupled with suggestions for coping with unwanted side effects will likely result in better management.

摘要

目的

评估女性对膀胱控制问题的认知。

方法

757名有一项或多项膀胱控制症状(尿频、尿急、压力性或急迫性尿失禁以及夜尿症)的女性参与了一项基于互联网的调查。另一项单独研究涉及12个焦点小组,共有180名有膀胱控制问题的女性。

结果

调查中的受访者报告了多种症状,如压力性尿失禁(72%)、尿频(56%)、夜尿症(45%)、急迫性尿失禁(43%)和尿急(33%)。调查和焦点小组中的女性都表明广泛使用应对机制来管理她们的症状。焦点小组显示,许多女性不知道膀胱过度活动症(OAB)是一种病理生理状况。调查中约30%的受访者表示与医生谈论自己的病情时感到不舒服。在与医生交谈的女性中,与压力相关的症状比与急迫相关的症状更容易被描述。在调查中,只有约一半(56%)的女性觉得她们的OAB药物有效,并且一半(50%)的女性在某个时候停止了服药。焦点小组的信息表明,一些女性可能对疗效的开始或益处的程度有不切实际的期望,并且可能对管理副作用没有准备。

结论

尴尬的感觉以及对OAB病理生理学的有限理解可能导致女性与医生之间的沟通不畅。对患者进行关于合理期望的教育以及应对不良副作用的建议可能会带来更好的管理。

相似文献

1
Perceptions and behaviours of women with bladder control problems.有膀胱控制问题的女性的认知与行为
Fam Pract. 2006 Oct;23(5):568-77. doi: 10.1093/fampra/cml018. Epub 2006 May 26.
2
Report of a mail survey of women with bladder control disorders.膀胱控制障碍女性的邮件调查结果报告。
Urol Nurs. 2004 Dec;24(6):499-507.
3
Understanding the elements of overactive bladder: questions raised by the EPIC study.了解膀胱过度活动症的要素:EPIC研究提出的问题
BJU Int. 2008 Jun;101(11):1381-7. doi: 10.1111/j.1464-410X.2008.07573.x. Epub 2008 Mar 10.
4
Overactive bladder in women: symptom impact and treatment expectations.女性膀胱过度活动症:症状影响与治疗期望
Curr Med Res Opin. 2005 Sep;21(9):1413-21. doi: 10.1185/030079905X59076.
5
Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes.索利那新用于治疗伴有尿失禁的膀胱过度活动症:症状困扰及与健康相关的生活质量结果
Ann Pharmacother. 2007 Mar;41(3):391-8. doi: 10.1345/aph.1H581. Epub 2007 Mar 6.
6
The causes and consequences of overactive bladder.膀胱过度活动症的病因及后果。
J Womens Health (Larchmt). 2006 Apr;15(3):251-60. doi: 10.1089/jwh.2006.15.251.
7
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
8
Health-related consequences of overactive bladder.膀胱过度活动症的健康相关后果。
Am J Manag Care. 2002 Dec;8(19 Suppl):S598-607.
9
Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT).索利那新治疗膀胱过度活动症后的症状困扰及健康相关生活质量结局:卫喜康开放标签试验(VOLT)
Clin Ther. 2006 Nov;28(11):1935-46. doi: 10.1016/j.clinthera.2006.11.010.
10
Impact of overactive bladder symptoms on employment, social interactions and emotional well-being in six European countries.膀胱过度活动症症状对六个欧洲国家就业、社交互动及情绪健康的影响
BJU Int. 2006 Jan;97(1):96-100. doi: 10.1111/j.1464-410X.2005.05889.x.

引用本文的文献

1
Real-World Adherence to and Persistence with Vibegron in Patients with Overactive Bladder: A Retrospective Claims Analysis.膀胱过度活动症患者对维贝格隆的真实世界依从性和持续性:一项回顾性索赔分析。
Adv Ther. 2024 May;41(5):2086-2097. doi: 10.1007/s12325-024-02824-x. Epub 2024 Mar 23.
2
Primary care providers practice patterns regarding female pelvic floor disorders.初级保健提供者在女性盆底疾病方面的实践模式。
Fam Med Community Health. 2024 Mar 14;12(1):e002448. doi: 10.1136/fmch-2023-002448.
3
Efficacy of botulinum toxin-A injection versus oral anticholinergic medications following transurethral resection of the prostate to manage bladder outlet obstruction with overactive bladder: a prospective randomized clinical trial study.
经尿道前列腺切除术后注射A型肉毒杆菌毒素与口服抗胆碱能药物治疗膀胱出口梗阻合并膀胱过度活动症的疗效:一项前瞻性随机临床试验研究。
Am J Clin Exp Urol. 2023 Jun 15;11(3):228-234. eCollection 2023.
4
Condition-specific validation of the Arabic version of the Prolapse and Incontinence Knowledge Questionnaire (PIKQ) among parturient.分娩妇女中脱垂和尿失禁知识问卷(PIKQ)阿拉伯文版的特定条件验证。
Int Urogynecol J. 2023 Jul;34(7):1529-1539. doi: 10.1007/s00192-022-05417-w. Epub 2022 Dec 14.
5
Long-term efficacy and safety of vibegron versus mirabegron and anticholinergics for overactive bladder: a systematic review and network meta-analysis.维贝格隆与米拉贝隆及抗胆碱能药物治疗膀胱过度活动症的长期疗效和安全性:一项系统评价和网状Meta分析
Drugs Context. 2022 Oct 10;11. doi: 10.7573/dic.2022-4-2. eCollection 2022.
6
Knowledge of women during the third trimester of pregnancy regarding pelvic floor disorders.孕妇在妊娠晚期对盆底功能障碍的认知。
Int Urogynecol J. 2022 Dec;33(12):3407-3414. doi: 10.1007/s00192-022-05098-5. Epub 2022 May 2.
7
A meta-ethnography to understand the experience of living with urinary incontinence: 'is it just part and parcel of life?'.一项荟萃民族志研究,旨在理解尿失禁患者的生活体验:“这只是生活的一部分吗?”
BMC Urol. 2020 Jan 16;20(1):1. doi: 10.1186/s12894-019-0555-4.
8
Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.影响英国初级保健中患者坚持和遵守处方膀胱过度活动症药物因素的定性分析。
Adv Ther. 2019 Nov;36(11):3110-3122. doi: 10.1007/s12325-019-01098-y. Epub 2019 Sep 26.
9
Knowledge of pelvic floor disorders in women seeking primary care: a cross-sectional study.女性在寻求初级保健时对盆底疾病的认知:一项横断面研究。
BMC Fam Pract. 2019 May 23;20(1):70. doi: 10.1186/s12875-019-0958-z.
10
Impact of LUTS on treatment-related behaviors and quality of life: A population-based study in Brazil.下尿路症状对治疗相关行为和生活质量的影响:巴西的一项基于人群的研究。
Neurourol Urodyn. 2019 Aug;38(6):1579-1587. doi: 10.1002/nau.24004. Epub 2019 Apr 29.